Mo1129 – Efficacy of Budesonide Orodispersible Tablets for Induction of Remission in Patients with Active Eosinophilic Esophagitis: Results from the 6-Weeks Open-Label Treatment Phase of Eos-2 Trial

Autor:	Michael Vieth, Alex Straumann, Roland Greinwald, Albert J. Bredenoord, Ralph Mueller, Cecilio Santander, Alfredo J. Lucendo, Petr Hruz, Luc Biedermann, Constanza Ciriza de los Ríos, Jamal O. Hayat, Stephan Miehlke, Dirk Hartmann, Christoph Schlag
Rok vydání:	2019
Předmět:	Budesonide medicine.medical_specialty Hepatology business.industry OPEN LABEL TREATMENT Gastroenterology medicine.disease Internal medicine medicine In patient Eosinophilic esophagitis business medicine.drug
Zdroj:	Gastroenterology. 156:S-715
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(19)38723-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::768b388e71602c6ca81177115aff8ea9 https://doi.org/10.1016/s0016-5085(19)38723-2 Zobrazit plný text záznamu